CORD-19:c654596857bce9cdd64ffc51842048643107348c / 101224-101393 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T833","span":{"begin":0,"end":169},"obj":"Sentence"},{"id":"T29454","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Oral oseltamivir, the ethyl ester pro-drug of a potent inhibitor of influenza virus neuraminidase, is licensed for the treatment and prophylaxis of influenza in the USA."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T16","span":{"begin":0,"end":169},"obj":"Sentence"}],"text":"Oral oseltamivir, the ethyl ester pro-drug of a potent inhibitor of influenza virus neuraminidase, is licensed for the treatment and prophylaxis of influenza in the USA."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T428","span":{"begin":68,"end":77},"obj":"Disease"},{"id":"T429","span":{"begin":148,"end":157},"obj":"Disease"},{"id":"T98854","span":{"begin":68,"end":77},"obj":"Disease"},{"id":"T398","span":{"begin":148,"end":157},"obj":"Disease"}],"attributes":[{"id":"A428","pred":"mondo_id","subj":"T428","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A429","pred":"mondo_id","subj":"T429","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A43278","pred":"mondo_id","subj":"T98854","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A40611","pred":"mondo_id","subj":"T398","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"Oral oseltamivir, the ethyl ester pro-drug of a potent inhibitor of influenza virus neuraminidase, is licensed for the treatment and prophylaxis of influenza in the USA."}